AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and Processes
Neurotoxicity SyndromesSyndromeNeurotoxinsDown SyndromeMetabolic Syndrome XNeuronsNephrotic SyndromeSjogren's SyndromeNeuroprotective AgentsNervous System DiseasesMethamphetamineBrainTurner SyndromeAmyloid beta-PeptidesManganese PoisoningAbnormalities, MultipleMyelodysplastic SyndromesNerve DegenerationN-Methyl-3,4-methylenedioxyamphetamineCushing SyndromeChlorpyrifosCells, CulturedMethylmercury CompoundsMercury Poisoning, Nervous SystemAcute Coronary SyndromePolycystic Ovary SyndromeNervous SystemMicrogliaDose-Response Relationship, DrugWilliams Syndrome1-Methyl-4-phenylpyridiniumDopaminePeripheral Nervous System DiseasesMPTP PoisoningDiGeorge SyndromeN-MethylaspartateCell DeathRats, Sprague-DawleyHorner SyndromePrader-Willi SyndromeLong QT Syndrome1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineCerebral CortexGuillain-Barre SyndromeHemolytic-Uremic SyndromeCompartment SyndromesDisease Models, AnimalTourette SyndromeGlutamic AcidAntiphospholipid SyndromeMutation
DeCS - Termos Novos
NEUROTOXICITY SYNDROMES SINDROMES DE NEUROTOXICIDAD SÍNDROMES PARANEOPLÁSICAS DO SISTEMA NERVOSO PARANEOPLASTIC SYNDROMES, ... CENTRAL CORD SYNDROME SINDROME DEL CORDON CENTRAL SÍNDROMES DA DOR REGIONAL COMPLEXA COMPLEX REGIONAL PAIN SYNDROMES SINDROMES ... TOLOSA-HUNT SYNDROME SINDROME DE TOLOSA-HUNT SÍNDROME DE UNVERRICHT-LUNDBORG UNVERRICHT-LUNDBORG SYNDROME SINDROME DE ... MYASTHENIC SYNDROMES, CONGENITAL SINDROMES MIASTENICOS CONGENITOS SÍNDROMES NEUROCUTÂNEAS NEUROCUTANEOUS SYNDROMES SINDROMES ...
https://decs2008.bvsalud.org/P/news2000pie.htm
DeCS - Termos Novos
NEUROTOXICITY SYNDROMES SINDROMES DE NEUROTOXICIDAD SÍNDROMES PARANEOPLÁSICAS DO SISTEMA NERVOSO PARANEOPLASTIC SYNDROMES, ... CENTRAL CORD SYNDROME SINDROME DEL CORDON CENTRAL SÍNDROMES DA DOR REGIONAL COMPLEXA COMPLEX REGIONAL PAIN SYNDROMES SINDROMES ... TOLOSA-HUNT SYNDROME SINDROME DE TOLOSA-HUNT SÍNDROME DE UNVERRICHT-LUNDBORG UNVERRICHT-LUNDBORG SYNDROME SINDROME DE ... MYASTHENIC SYNDROMES, CONGENITAL SINDROMES MIASTENICOS CONGENITOS SÍNDROMES NEUROCUTÂNEAS NEUROCUTANEOUS SYNDROMES SINDROMES ...
https://decs2012.bvsalud.org/P/news2000pie.htm
DeCS - Termos Novos
NEUROTOXICITY SYNDROMES SINDROMES DE NEUROTOXICIDAD SÍNDROMES PARANEOPLÁSICAS DO SISTEMA NERVOSO PARANEOPLASTIC SYNDROMES, ... CENTRAL CORD SYNDROME SINDROME DEL CORDON CENTRAL SÍNDROMES DA DOR REGIONAL COMPLEXA COMPLEX REGIONAL PAIN SYNDROMES SINDROMES ... TOLOSA-HUNT SYNDROME SINDROME DE TOLOSA-HUNT SÍNDROME DE UNVERRICHT-LUNDBORG UNVERRICHT-LUNDBORG SYNDROME SINDROME DE ... MYASTHENIC SYNDROMES, CONGENITAL SINDROMES MIASTENICOS CONGENITOS SÍNDROMES NEUROCUTÂNEAS NEUROCUTANEOUS SYNDROMES SINDROMES ...
https://decs2013.bvsalud.org/P/news2000pie.htm
DeCS - Termos Novos
NEUROTOXICITY SYNDROMES SINDROMES DE NEUROTOXICIDAD SÍNDROMES PARANEOPLÁSICAS DO SISTEMA NERVOSO PARANEOPLASTIC SYNDROMES, ... CENTRAL CORD SYNDROME SINDROME DEL CORDON CENTRAL SÍNDROMES DA DOR REGIONAL COMPLEXA COMPLEX REGIONAL PAIN SYNDROMES SINDROMES ... TOLOSA-HUNT SYNDROME SINDROME DE TOLOSA-HUNT SÍNDROME DE UNVERRICHT-LUNDBORG UNVERRICHT-LUNDBORG SYNDROME SINDROME DE ... MYASTHENIC SYNDROMES, CONGENITAL SINDROMES MIASTENICOS CONGENITOS SÍNDROMES NEUROCUTÂNEAS NEUROCUTANEOUS SYNDROMES SINDROMES ...
https://decs2014.bvsalud.org/P/news2000pie.htm
Frontiers | The Neuroinflammatory Etiopathology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)Frontiers | The Neuroinflammatory Etiopathology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a debilitating multi-systemic chronic illness of unknown ... Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a debilitating multi-systemic chronic illness of unknown ... Giordano, G., and Costa, L. (2012). Developmental neurotoxicity: some old and new issues. ISRN Toxicol. 2012:814795. doi: ... Orthostatic intolerance and chronic fatigue syndrome associated with Ehlers-Danlos syndrome. J. Pediatr. 135, 494-499. doi: ...
https://www.frontiersin.org/articles/10.3389/fphys.2017.00088/full
Biblio | College of Agricultural SciencesBiblio | College of Agricultural Sciences
Filters: Keyword is Neurotoxicity Syndromes and Author is Tamara L Tal [Clear All Filters] ... T. L. Tal and Tanguay, R. L., "Non-coding RNAs--novel targets in neurotoxicity.", Neurotoxicology, vol. 33, no. 3, pp. 530-44, ...
https://owri.oregonstate.edu/biblio?f%5Bkeyword%5D=17206&f%5Bauthor%5D=1776&s=year&o=asc
The EPA National Library Catalog | EPA National Library Network | US EPA
Neurotoxicity Syndromes--etiology ; Thimerosal--toxicity ; MEDICAL--Preventive Medicine ; MEDICAL--Forensic Medicine ; MEDICAL ... Public Health ; Vaccination--adverse effects--Child ; Vaccines--adverse effects--Child ; Neurotoxicity Syndromes--etiology-- ...
https://cfpub.epa.gov/ols/catalog/advanced_bibliography.cfm?&FIELD1=SUBJECT&INPUT1=Vaccination%20adverse%20effects%20Child&TYPE1=EXACT&LOGIC1=AND&COLL=&SORT_TYPE=MTIC&start_row=1
Mosunetuzumab for Aggressive Lymphoma: 'Not a Home Run'
And in terms of safety, this drug is well tolerated; there is not a lot of neurotoxicity, and the cytokine release syndrome ... Clinical Picture, Outcome and Predictive Factors of Lymphoma in Primary Sjögrens Syndrome ...
https://www.staging.medscape.com/viewarticle/922608
Parkinson-Plus Syndromes: Clues to Diagnosis, Multiple System Atrophy, Progressive Supranuclear PalsyParkinson-Plus Syndromes: Clues to Diagnosis, Multiple System Atrophy, Progressive Supranuclear Palsy
Excessive iron may produce neurotoxicity because of its role in oxidation and reduction reactions. This type of oxidative ... Diagnosis and Management of Parkinson-Plus Syndromes. Patients with parkinsonian syndromes unresponsive to dopamine agonists or ... In 1960, Shy and Drager described a neurologic syndrome (Shy-Drager syndrome [SDS]) of orthostatic hypotension with ... encoded search term (Parkinson-Plus Syndromes) and Parkinson-Plus Syndromes What to Read Next on Medscape ...
https://emedicine.medscape.com/article/1154074-overview
DailyMed - LUPKYNIS- voclosporin capsuleDailyMed - LUPKYNIS- voclosporin capsule
The most severe neurotoxicities include posterior reversible encephalopathy syndrome (PRES), delirium, seizure, and coma; ... Neurotoxicity: Including risk of posterior reversible encephalopathy syndrome (PRES); monitor for neurologic abnormalities; ... 5.5 Neurotoxicity. LUPKYNIS, like other calcineurin-inhibitors, may cause a spectrum of neurotoxicities [see Adverse Reactions ... 5.5 Neurotoxicity 5.6 Hyperkalemia 5.7 QTc Prolongation 5.8 Immunizations 5.9 Pure Red Cell Aplasia 6 ADVERSE REACTIONS 6.1 ...
https://www.dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9f489295-1156-52c7-5fd0-5c4c52f9b813
Event 3: Pharmacotherapy | COEPESEvent 3: Pharmacotherapy | COEPES
Increased risk of serotonin syndrome, neurotoxicity, and/or seizures. Dopamine-2 antagonists (e.g. metoclopramide). ... Increased risk of extrapyramidal reactions / neuroleptic malignant syndrome. Antiplatelets / anticoagulants/ NSAIDs. Major. ... and signs and symptoms of serotonin syndrome ...
https://coepes.nih.gov/module/mr-wakefield-wounded-warrier/event-3-pharmacotherapy
Galapagos to showcase CAR-T point-of-care manufacturing and initial Phase 1/2 CLL data with CD19 CAR-T candidate, GLPG5201, at...Galapagos to showcase CAR-T point-of-care manufacturing and initial Phase 1/2 CLL data with CD19 CAR-T candidate, GLPG5201, at...
... or immune effector cell-associated neurotoxicity syndrome (ICANS)2 A functionally closed, automated manufacturing platform for ... 1 GLPG5201 showed no cytokine release syndrome (CRS) higher than grade 2, ... GLPG5201 showed no cytokine release syndrome (CRS) higher than grade 2, or immune effector cell-associated neurotoxicity ... syndrome (ICANS)2 *A functionally closed, automated manufacturing platform for cell therapies at the point-of-care will be ...
https://kommunikasjon.ntb.no/pressemelding/17971810/galapagos-to-showcase-car-t-point-of-care-manufacturing-and-initial-phase-12-cll-data-with-cd19-car-t-candidate-glpg5201-at-the-eha-2023-congress?publisherId=4954260
CAR T Cells and Toxicities/Efficacy | Society for Translational OncologyCAR T Cells and Toxicities/Efficacy | Society for Translational Oncology
... including cytoxine release syndrome (CRS) and immune cell associated neurotoxicity syndrome (ICANS). She presented a case of a ... and neurotoxicity or immune cell associated neurotoxicity syndrome (ICANS). Being a neurologist by training, Dr. Santomasso ... unique and prominent toxicities including cytokine release syndrome (CRS) and immune cell associated neurotoxicity syndrome ( ... including cytokine release syndrome and neurotoxicity.. CAR-T cells are T cells isolated from a patient and engineered to ...
https://sto-online.org/CAR-T-Cells-and-Toxicities-Efficacy
Juno Advances CAR T-cell CAR017 and Halts CAR015 in Non-Hodgkin Lymphoma | Cancer BiologyJuno Advances CAR T-cell CAR017 and Halts CAR015 in Non-Hodgkin Lymphoma | Cancer Biology
None of the patients experienced severe cytokine release syndrome (CRS) and fourteen percent experienced neurotoxicity, which ... and grade 3 neurotoxicity was seen in 23% of patients. ... and twenty-nine percent had grade 3 or 4 neurotoxicity. ...
https://blogs.shu.edu/cancer/2017/03/08/juno-advances-car-t-cell-car017-and-halts-car015-in-non-hodgkin-lymphoma/
OPUS 4 | SearchOPUS 4 | Search
... short-term complications including cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome, ...
https://publikationen.ub.uni-frankfurt.de/solrsearch/index/search/searchtype/authorsearch/author/Bj%C3%B6rn+Kr%C3%B6ger
CAR-T Cell Therapy: The other side of the coinCAR-T Cell Therapy: The other side of the coin
... and neurotoxicities were presented and discussed in a symposium. ... cytokine release syndrome, and neurotoxicity were presented and ... The two most important side effects, cytokine release syndrome, ... and immune cell-associated neurotoxicity syndrome (ICANS). Up ... The two most important side effects, cytokine release syndrome, and neurotoxicities were presented and discussed in a symposium ... The two most important side effects, cytokine release syndrome, and neurotoxicities were presented and discussed in a symposium ...
https://www.esanum.com/today/posts/car-t-cell-therapy-the-other-side-of-the-coin
LONG-TERM FOLLOW-UP RESULTS OF A MULTICENTER FIRST-IN-HUMAN STUDY.... EHA Library. Du J. Jun 9 2021; 325720
No grade 4/5 CRS or Immunce effector cell-associated Neurotoxicity syndrome (ICANS) were observed. 2 deaths occurred on study ... No grade 4/5 CRS or Immunce effector cell-associated Neurotoxicity syndrome (ICANS) were observed. 2 deaths occurred on study ... Cytokine Release Syndrome (CRS) and ICANs were graded by ASBMTcriteria: grade 1-2 n=16 (84.2%), grade 3 n=2 (10.5%). Median ... Cytokine Release Syndrome (CRS) and ICANs were graded by ASBMTcriteria: grade 1-2 n=16 (84.2%), grade 3 n=2 (10.5%). Median ...
https://library.ehaweb.org/eha/2021/eha2021-virtual-congress/325720/juan.du.long-term.follow-up.results.of.a.multicenter.first-in-human.study.of.html
Coordination and Maintenance Committee Presses Forward Despite Pandemic - ICD10monitorCoordination and Maintenance Committee Presses Forward Despite Pandemic - ICD10monitor
Immune effector cell associated neurotoxicity syndrome (ICANS). *Complications of immune effector cellular (IEC) therapy ...
https://icd10monitor.medlearn.com/coordination-and-maintenance-committee-presses-forward-despite-pandemic-202009072114/
SEC Filing | Caribou Biosciences, Inc.SEC Filing | Caribou Biosciences, Inc.
... immune effector cell-associated neurotoxicity syndrome; TEAE: treatment-emergent adverse event 1 Four total events, 2 Grade 1; ... Cytokine release syndrome 7 (44) - - White blood cell count decreased 7 (44) 7 (44) 4 (25) Fatigue 4 (25) - - Lymphocyte count ... cytokine release syndrome; DLT: dose-limiting toxicity; GvHD: graft-versus-host-disease; ICANS: ... decreased 4 (25) 3 (19) 1 (6) Blood creatinine increased 4 (25) - - ICANS (immune effector cell-associated neurotoxicity) 4 (25 ...
https://investor.cariboubio.com/node/8091/html
Human Genome Epidemiology Literature Finder|Home|PHGKB
No article was found for Neurotoxicity Syndromes and INSC[original query]. File Formats Help:. How do I view different file ...
https://phgkb.cdc.gov/PHGKB/searchSummary.action?firstQuery=Neurotoxicity%20Syndromes+and+INSC&Mysubmit=Search
Huntingtin Recombinant Protein Antigen (NBP1-89710PEP): Novus BiologicalsHuntingtin Recombinant Protein Antigen (NBP1-89710PEP): Novus Biologicals
Neurotoxicity Syndromes. *Alzheimers Disease. *Nervousness. *Nervous System Disorder. *Impaired Cognition. *Ataxia. *Parkinson ...
https://www.novusbio.com/products/huntingtin-protein_nbp1-89710pep
Corey Fehnel | Harvard Catalyst Profiles | Harvard CatalystCorey Fehnel | Harvard Catalyst Profiles | Harvard Catalyst
Neurotoxicity Syndromes * Brain Abscess * Decompressive Craniectomy * Infarction, Posterior Cerebral Artery Explore _. Co- ...
https://connects.catalyst.harvard.edu/Profiles/display/Person/39295
Eg5 Antibody (NB100-57514): Novus BiologicalsEg5 Antibody (NB100-57514): Novus Biologicals
Neurotoxicity Syndromes. *Dysequilibrium Syndrome. *Malignant Paraganglionic Neoplasm. *Gait, Drop Foot. *Malignant Neoplasm Of ...
https://www.novusbio.com/products/eg5-antibody_nb100-57514
Adaptive single-KIR+NKG2C+ NK cells expanded from select superdonors show potent missing-self reactivity and efficiently...Adaptive single-KIR+NKG2C+ NK cells expanded from select superdonors show potent missing-self reactivity and efficiently...
Adoptive transfer of allogeneic NK cells has a good safety profile without cytokine release syndrome, neurotoxicity, or GvH ...
https://jitc.bmj.com/content/10/11/e005577.full
Cancer Breakthrough: New T-Cell Therapy Produces Extraordinary Results In Terminal Blood Cancer PatientsCancer Breakthrough: New T-Cell Therapy Produces 'Extraordinary' Results In Terminal Blood Cancer Patients
Theyve previously been associated with cytokine release syndrome, a condition that can lead to hypotension, neurotoxicity, or ...
https://www.medicaldaily.com/cancer-breakthrough-t-cell-therapy-terminally-ill-373697
Brain Plasticity - Volume 1, issue 1 - Journals - IOS PressBrain Plasticity - Volume 1, issue 1 - Journals - IOS Press
Keywords: Exercise, methamphetamine, addiction, animal models, reward, relapse, neurogenesis, neurotoxicity syndromes, neuronal ... The review highlights how methamphetamine and exercise affect neuronal plasticity and neurotoxicity in the adult mammalian ...
https://ip.ios.semcs.net/journals/brain-plasticity/1/1
TALVEY™ (talquetamab-tgvs) FDA Approved for Super Refractory Multiple MyelomaTALVEY™ (talquetamab-tgvs) FDA Approved for Super Refractory Multiple Myeloma
Neurotoxicity including ICANS (Immune Effector Cell-Associated Neurotoxicity Syndrome). *Oral toxicity manifests as altered ... Skin toxicity may manifest as a rash or may be severe and manifest as Steven-Johnson syndrome. ...
https://emedz.net/blog/talvey-talquetamab
Cancers | September-2 2023 - Browse ArticlesCancers | September-2 2023 - Browse Articles
Cytokine release syndrome incidence was 88%; immune effector cell-associated neurotoxicity syndrome incidence was 56%. All- ...
https://www2.mdpi.com/2072-6694/15/18
Citations and Studies - Rave SupplementCitations and Studies - Rave Supplement
Recreational Ecstasy/MDMA, the Serotonin Syndrome, and Serotonergic Neurotoxicity. 18 Sept. 2001. Web. 30 Apr. 2017. ... Parrott, A. C. "Recreational Ecstasy/MDMA, the Serotonin Syndrome, and Serotonergic Neurotoxicity." Pharmacology, Biochemistry ... "What Is Neurotoxicity?" News-Medical.net. N.p., 02 Dec. 2014. Web. 30 Mar. 2017. ... Parrott, A.C. "Recreational MDMA (Ecstasy) Use and Serotonergic Neurotoxicity." The Neuroscientist 5.3 (1999): 141. ...
https://ravesupplement.com/pages/citations-and-studies